We are live on ! Find out more
AMED

Amedisys
AMED

Delisted

AMED was delisted on the 14th of August, 2025.

Back to rankings

288 hedge funds and large institutions have $2.85B invested in Amedisys in 2024 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 93 increasing their positions, 104 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 32

18% more funds holding in top 10

Funds holding in top 10: 11 → 13 (+2)

2% more funds holding

Funds holding: 283 → 288 (+5)

0.07% more ownership

Funds ownership: 94.92% → 94.99% (+0.07%)

0% less capital invested

Capital invested by funds: $2.86B → $2.85B (-$5.8M)

11% less repeat investments, than reductions

Existing positions increased: 93 | Existing positions reduced: 104

82% less call options, than puts

Call options by funds: $17.1M | Put options by funds: $94.3M

Holders
288
Holders Change
+5
Holders Change %
+1.77%
% of All Funds
4.16%
Holding in Top 10
13
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+18.18%
% of All Funds
0.19%
New
42
Increased
93
Reduced
104
Closed
32
Calls
$17.1M
Puts
$94.3M
Net Calls
-$77.2M
Net Calls Change
-$8.21M

Top Buyers

1
Goldman Sachs
Goldman Sachs
New York
+$96.9M
2
FCM
Farallon Capital Management
California
+$27.9M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$19.4M
4
LP
LMR Partners
United Kingdom
+$18.5M
5
SGCM
Sand Grove Capital Management
United Kingdom
+$17.5M

Top Sellers

1
Millennium Management
Millennium Management
New York
-$32.3M
2
PWAM
Park West Asset Management
California
-$29.6M
3
WP
Woodline Partners
California
-$19.5M
4
MAM
Melqart Asset Management
United Kingdom
-$18.9M
5
Boston Partners
Boston Partners
Massachusetts
-$18.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
FTCM
101
First Trust Capital Management
Illinois
$2.18M -$503K -5,416 -19%
Walleye Capital
102
Walleye Capital
New York
$2.12M -$133K -1,433 -6%
Cetera Investment Advisers
103
Cetera Investment Advisers
Illinois
$2.09M +$443K +4,773 +27%
Manulife (Manufacturers Life Insurance)
104
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.08M -$63.6K -685 -3%
YCM
105
Yakira Capital Management
Connecticut
$2.07M – – –
Ohio Public Employees Retirement System (OPERS)
106
Ohio Public Employees Retirement System (OPERS)
Ohio
$2M -$3.71K -40 -0.2%
OR
107
Olympiad Research
Connecticut
$1.92M – – –
State of New Jersey Common Pension Fund D
108
State of New Jersey Common Pension Fund D
New Jersey
$1.84M -$889K -9,583 -32%
VAM
109
Vazirani Asset Management
New York
$1.84M +$1.86M +20,000 New
SSA
110
Schonfeld Strategic Advisors
New York
$1.74M +$881K +9,496 +100%
JSL
111
JT Stratford LLC
Georgia
$1.73M -$239K -2,573 -12%
MOACM
112
Mutual of America Capital Management
New York
$1.72M -$70.4K -759 -4%
AB
113
Amalgamated Bank
New York
$1.7M -$319K -3,438 -16%
MIM
114
MetLife Investment Management
New Jersey
$1.58M -$68.8K -742 -4%
MCI
115
MRP Capital Investments
Georgia
$1.52M -$219K -2,365 -12%
T. Rowe Price Associates
116
T. Rowe Price Associates
Maryland
$1.51M -$1.37M -14,784 -47%
CL
117
CSS LLC
Illinois
$1.49M -$130K -1,400 -8%
Verition Fund Management
118
Verition Fund Management
Connecticut
$1.49M -$5.64M -60,793 -79%
Holocene Advisors
119
Holocene Advisors
New York
$1.48M +$1.49M +16,083 New
SO
120
STRS Ohio
Ohio
$1.4M -$211K -2,276 -13%
Nisa Investment Advisors
121
Nisa Investment Advisors
Missouri
$1.4M – – –
GCP
122
GSA Capital Partners
United Kingdom
$1.29M +$1.31M +14,100 New
YCM
123
Yousif Capital Management
Michigan
$1.29M -$95.6K -1,030 -7%
PFMU
124
Privium Fund Management (UK)
United Kingdom
$1.28M +$1.3M +13,984 New
Treasurer of the State of North Carolina
125
Treasurer of the State of North Carolina
North Carolina
$1.28M -$32.9K -355 -2%
3 4
5
6 7

AMED Hedge Fund Activity: Q2 2024 in Review

288 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2024, worth a combined $2.85B — down 0.2% from $2.86B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new AMED positions and 32 closed out — a net gain of 10 holders — while 93 added to existing stakes and 104 trimmed.

The largest buyer was Goldman Sachs, adding an estimated $96.9M. The largest seller was Millennium Management, cutting an estimated $32.3M.

  • 288 institutional investors held Amedisys (AMED) as of Q2 2024, up from 283 in Q1 2024.
  • Funds reported $2.85B of Amedisys stock for Q2 2024, down 0.2% quarter-over-quarter.
  • 42 funds opened new Amedisys positions in Q2 2024 and 32 closed out, a net change of +10 holders.
  • The largest Amedisys buyer in Q2 2024 was Goldman Sachs, an estimated $96.9M added.
  • The largest Amedisys seller in Q2 2024 was Millennium Management, an estimated $32.3M sold.

Based on aggregated 13F filings for Q2 2024.